
News|Articles|October 1, 2012
From the American College of Cardiology Annual Scientific Session & Expo 2012: Modifying antiplatelet therapy based on platelet function testing does not improve outcomes in stroke/TIA patients
In the quest to adopt personalized medicine approaches, optimizing antiplatelet therapy based on platelet function testing is controversial.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
3
TrumpRx launches; some experts question its long-term value
4
Cancer survival fell and deaths rose during first two years of COVID-19
5























